OOIR: Observatory of International Research

Papers

(The H4-Index of Pharmacotherapy is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Changes in serum potassium in people with type 2 diabetes taking sodium‐glucose co‐transporter‐2 inhibitors	119
Empiric dosing strategies to predict lamotrigine concentrations during pregnancy	108
	82
Warfarin dosage in a postpartum woman while breastfeeding: A case report	67
Assessment and management of iatrogenic withdrawal syndrome and delirium in pediatric intensive care units across Europe: An ESPNIC survey	59
Hydroxyurea treatment for sickle cell anemia during pregnancy and lactation: Current evidence and knowledge gaps	55
Safety and efficacy of cefiderocol for off‐label treatment indications: A systematic review	47
Correction to “Relationship of the Revised Anticholinergic Drug Scale With Cultured Cell‐Based Serum Anticholinergic Activity and Cognitive Measures in Older Adults With Mild Cognitive Impairment or R	42
Update and narrative review of avian influenza (H5N1) infection in adult patients	41
Acid‐suppressive drugs: A systematic review and network meta‐analysis of their nocturnal acid‐inhibitory effect	38
Characterization of lamotrigine disposition changes during and after pregnancy in women with epilepsy	38
Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care	35
	33
Comparative safety and efficacy of bisphosphonates, denosumab, and parathyroid hormone analogs for osteoporosis following lung transplantation	32
Biomarkers in the intensive care setting: A focus on using procalcitonin and C‐reactive protein to optimize antimicrobial duration of therapy	32
Response to comment on “Dosing implications for liposomal amphotericin B in pregnancy”	31
Patient safety outcomes for continuous infusion vancomycin as outpatient parenteral antimicrobial therapy	30
Reduced risk of NSAID‐Induced adverse events with concomitant use of misoprostol (MICRO study)	28
Optimal starting dosing regimen of intravenous oxytocin for labor induction based on the population kinetic‐pharmacodynamic model of uterine contraction frequency	28
Impact of concurrent gabapentin or pregabalin with high‐dose melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant	28
Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution	24
Comment on “Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution”	24
Determination of vancomycin exposure target and individualized dosing recommendations for critically ill patients undergoing continuous renal replacement therapy	23